We are about to cure multiple sclerosis in the next 10 years,even though we do not know its cause: Yes

Abstract

Proposal

Never underestimate the pervasive, powerful influence of constructive chaos in medical progress

Get full access to this article

View all access options for this article.

References

Rivers

Sprunt

Berry

. Observations on attempts to to produce acute disseminated encephalomyelitis in monkeys. J Exper Med 1933; 58: 39–53.

Zamboni

Galeotti

Menegatti

. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 392–399.

International Multiple Sclerosis Genetics Consortium. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

Ebers

Sadovnick

. The geographic distribution of multiple sclerosis: A review. Neuroepidemiology 1993; 12: 1–5.

Handunnetthi

Ramagopalan

Ebers

. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 2010; 74: 1905–1910.

Yednock

Cannon

Fritz

. Prevention of experimental autoimmune encephalomylitis by atibodies against alpha-4-beta-1 intergin. Nature 1992; 356: 63–66.

The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing–remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655–661.

Panitch

Hirsch

Haley

. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893–895.